Loading company details...
Beta
Latest Form 4 (Oct 31, 2024): Andrew Hykes (President and CEO): Sale of 3,000 shares, $150.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 31, 2024 | Andrew Hykes, President and CEO | Sale | 3,000 | $150.0K |
| Oct 31, 2024 | William Hoffman | Sale | 20,000 | $1.00M |
| Oct 18, 2024 | William Hoffman | Sale | 27,804 | $1.25M |
| Oct 3, 2024 | Kevin T. Strange, Chief Financial Officer | Grant/Award | 5,695 | n/a |
| Oct 3, 2024 | Thomas Tu, Chief Medical Officer | Tax Withholding | 339 | $13.8K |
| Oct 3, 2024 | Andrew Hykes, President and CEO | Tax Withholding | 508 | $20.6K |
| Oct 3, 2024 | William Hoffman | Tax Withholding | 678 | $27.5K |
| Oct 2, 2024 | Hill, Mitch C., Chief Financial Officer | Tax Withholding | 331 | $13.4K |
| Sep 18, 2024 | William Hoffman | Sale | 32,614 | $1.49M |
| Sep 13, 2024 | Hill, Mitch C., Chief Financial Officer | Exercise/Conversion | 3,000 | $1.4K |